Prelude Therapeutics Inc (NASDAQ:PRLD)

5.32
Delayed Data
As of 3:59pm ET
 +0.10 / +1.92%
Today’s Change
3.87
Today|||52-Week Range
43.55
-57.27%
Year-to-Date

Today’s Trading

Previous close5.22
Today’s open5.44
Day’s range5.17 - 5.45
Volume3,396
Average volume (3 months)256,340
Market cap$260.4M
Data as of 3:59pm ET, 07/01/2022

Growth & Valuation

Earnings growth (last year)-80.13%
Earnings growth (this year)-6.69%
Earnings growth (next 5 years)-3.32%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.91

Competitors

No competitors data available.

Financials

Next reporting dateAugust 11, 2022
EPS forecast (this quarter)-$0.63
Annual revenue (last year)$0.00
Annual profit (last year)-$111.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts